Q3 2017 Holdings
Filed 2017-11-14 | 26 holdings | $53.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.5M | 200,000 | 43.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $17.0M | 255,000 | 31.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $9.8M | 1,475,000 | 18.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.2M | 177,500 | 6.0% |
| Loxo Oncology Inc | COM | 548862101 | $33.2K | 360,000 | 0.1% |
| Myokardia Inc | COM | 62857M105 | $24.0K | 560,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $21.0K | 1,400,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $20.8K | 298,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $19.9K | 145,000 | 0.0% |
| Foundation Medicine Inc | COM | 350465100 | $19.3K | 480,000 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $19.1K | 106,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $18.7K | 209,474 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $16.8K | 815,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $15.0K | 240,000 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $14.4K | 1,500,000 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $14.2K | 795,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $11.8K | 380,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $11.2K | 400,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $10.5K | 127,500 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $8.8K | 44,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $6.2K | 399,825 | 0.0% |
| Tesaro Inc | COM | 881569107 | $5.0K | 38,500 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $3.8K | 256,215 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $3.2K | 133,333 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $2.2K | 550,000 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.8K | 207,500 | 0.0% |